Alzheimer's Clinical Trial Results, Sadly Running True To Form
2025-12-04 06:30:00 ET
Originally published on November 25, 2025
There have been some interesting failures recently in Alzheimer’s trials. As long-time readers will know, I consider basically all Alzheimer’s drug trials to have failed to one degree or another, and particularly when it comes to clearing the “will improve patient’s lives in the real world without putting them at too much risk” hurdle. But these two are notable because they’re aimed outside the usual amyloid zone....
Read the full article on Seeking Alpha
For further details see:
Alzheimer's Clinical Trial Results, Sadly Running True To FormNASDAQ: VYGR
VYGR Trading
20.25% G/L:
$4.90 Last:
3,390,448 Volume:
$4.11 Open:



